Skip to main content
New Yearโ€™s Sale โ€” Build a balanced news diet with 40% off Vantage
Published โ€ข loading... โ€ข Updated

CorriXR announces major deal to develop at-home lung cancer treatment

The life science startup has inked a deal to develop a pioneering inhalable therapy to treat lung cancer with Merxin Ltd and InhaTarget Therapeutics. The post ๐Ÿ”’ CorriXR announces major deal to develop at-home lung cancer treatment appeared first on Delaware Business Times.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

Bias Distribution

  • 100% of the sources are Center
100% Center

Factualityย Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Delaware Business Times broke the news in on Friday, January 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal